羟氯喹血药浓度可预测羟氯喹视网膜病变
该研究基于537例系统性红斑狼疮(SLE)患者队列,重复测量羟氯喹(HCQ)血药浓度并检测视网膜病变。结果显示总体视网膜病变频率为4.3%,较高HCQ血药浓度可预测后续视网膜病变,提示监测血药浓度有助于识别高危患者并调整剂量或加强监测。
要点
- HCQ视网膜病变总体频率为4.3%(23/537例SLE患者)。
- 较高平均和最大HCQ血药浓度可预测后续视网膜病变(P=0.0124和P=0.0340)。
- 高龄、较高BMI和较长HCQ用药时长与视网膜毒性风险升高相关。
核心结论
- 评估HCQ血药浓度可用于预测视网膜病变,有助于对高血药浓度患者降低剂量或加强监测。
研究设计与样本
- 来自大型临床队列的537例SLE患者,重复测量HCQ血药浓度并检测HCQ视网膜病变,按临床特征和血药浓度评估视网膜病变风险。
主要发现
- 视网膜病变总体频率为4.3%(23/537例)。
- HCQ治疗第1个5年视网膜病变风险为1%,第6至10年为1.8%,第11至15年为3.3%,第16至20年为11.5%,21年后为8.0%。
- 较高年龄(P<0.0001)、较高BMI(趋势P=0.0160)和较长HCQ用药时长(P=0.0024,趋势P=0.0006)与较高HCQ毒性风险相关。
- 较高平均和最大HCQ血药浓度可预测后续HCQ视网膜病变(P=0.0124和P=0.0340)。
临床怎么用
- 临床可评估HCQ血药浓度以预测视网膜病变风险,对高血药浓度患者考虑降低剂量或加强监测。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: In 2016, the American Academy of Ophthalmology (AAO) changed the recommended daily dose of hydroxychloroquine (HCQ) from 6.5 mg/kg to <5 mg/kg. However, it is not clear that the lower prescribed dose of HCQ will have the same efficacy for systemic lupus erythematosus (SLE) activity or the same role in protecting against cardiovascular risk factors and thrombosis. This study was undertaken to address the frequency of HCQ retinopathy and the role of HCQ blood levels in identifying those individuals who are at a greater future risk of retinopathy. METHODS: HCQ blood levels in 537 patients with SLE from a large clinical cohort were repeatedly measured, and patients were tested for HCQ retinopathy. We assessed the risk of retinopathy according to clinical characteristics and blood levels of HCQ. RESULTS: The overall frequency of retinopathy was 4.3% (23 of 537 patients). There was a 1% risk of retinopathy in the first 5 years of HCQ treatment, 1.8% from 6 to 10 years, 3.3% from 11 to 15 years, 11.5% from 16 to 20 years, and 8.0% after 21 years of use. We found that older age (P < 0.0001), higher body mass index (P for trend = 0.0160), and longer duration of HCQ intake (P = 0.0024 and P for trend = 0.0006) were associated with a higher risk of HCQ toxicity. Higher blood levels of HCQ predicted later HCQ retinopathy (P = 0.0124 and P = 0.0340 for mean and maximum HCQ blood levels, respectively). CONCLUSION: Our data prove the utility of assessing blood levels of HCQ in the prediction of retinopathy. This would allow clinicians to either decrease the dose or increase monitoring in those patients with high HCQ blood levels.
引用
- Petri M, Elkhalifa M, Li J, et al. Hydroxychloroquine Blood Levels Predict Hydroxychloroquine Retinopathy. Arthritis Rheumatol. 2020. PMID: 31532077. doi:10.1002/art.41121
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。